IRIS
ODDO, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.561
NA - Nord America 3.356
AS - Asia 1.810
SA - Sud America 585
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 62
OC - Oceania 10
Totale 9.534
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.207
RU - Federazione Russa 2.099
SG - Singapore 823
BR - Brasile 497
IE - Irlanda 496
CN - Cina 317
HK - Hong Kong 299
SE - Svezia 296
IT - Italia 232
FR - Francia 130
IN - India 87
DE - Germania 81
CA - Canada 66
VN - Vietnam 62
GB - Regno Unito 53
BD - Bangladesh 47
NL - Olanda 40
AR - Argentina 37
FI - Finlandia 26
ZA - Sudafrica 23
JP - Giappone 22
AT - Austria 21
PL - Polonia 20
MX - Messico 17
TR - Turchia 17
PK - Pakistan 16
EC - Ecuador 15
ES - Italia 14
IQ - Iraq 12
MY - Malesia 12
TT - Trinidad e Tobago 12
UA - Ucraina 11
ID - Indonesia 10
JM - Giamaica 10
CO - Colombia 9
EU - Europa 9
MA - Marocco 9
SA - Arabia Saudita 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
IL - Israele 8
LT - Lituania 8
CZ - Repubblica Ceca 7
NI - Nicaragua 7
PH - Filippine 7
PY - Paraguay 7
SV - El Salvador 7
TH - Thailandia 7
TN - Tunisia 7
EG - Egitto 6
GT - Guatemala 6
UZ - Uzbekistan 6
CL - Cile 5
KE - Kenya 5
BB - Barbados 4
BE - Belgio 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HN - Honduras 4
JO - Giordania 4
KR - Corea 4
NP - Nepal 4
PE - Perù 4
SC - Seychelles 4
TW - Taiwan 4
DK - Danimarca 3
ET - Etiopia 3
KW - Kuwait 3
KZ - Kazakistan 3
LK - Sri Lanka 3
PR - Porto Rico 3
PT - Portogallo 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
DZ - Algeria 2
GE - Georgia 2
GR - Grecia 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
FJ - Figi 1
GD - Grenada 1
GN - Guinea 1
GP - Guadalupe 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
Totale 9.384
Salva come PNG Salva come JPEG
Città #
Ashburn 635
Moscow 587
Dublin 496
Singapore 444
San Jose 352
Hong Kong 298
Nyköping 277
Dallas 260
Council Bluffs 168
The Dalles 127
Los Angeles 94
Lauterbourg 88
Chandler 86
Princeton 86
Medford 85
Walnut 84
Des Moines 66
Messina 59
Pune 48
Buffalo 44
Santa Clara 44
Beijing 43
Redondo Beach 39
São Paulo 36
Tianjin 36
Brooklyn 34
New York 33
Munich 29
Ho Chi Minh City 27
Orem 25
Rio de Janeiro 25
Boardman 22
Tokyo 21
Columbus 20
Guangzhou 20
Phoenix 20
Atlanta 19
North Bergen 19
Nuremberg 19
Montreal 18
Rome 17
Toronto 16
Amsterdam 15
Warsaw 15
Wilmington 14
Frankfurt am Main 13
Johannesburg 13
San Francisco 13
Turku 12
Vienna 12
Carrboro 11
Chennai 11
Chicago 11
Dhaka 11
Hanoi 11
Denver 10
Shanghai 10
Shenzhen 10
Belo Horizonte 9
Boston 9
Porto Alegre 9
Stockholm 9
Catania 8
Düsseldorf 8
Guarulhos 8
Jiaxing 8
Naples 8
Brno 7
Campinas 7
Jinan 7
Kingston 7
Palermo 7
Philadelphia 7
San Salvador 7
Chaguanas 6
Charlotte 6
Goiânia 6
Houston 6
Hyderabad 6
Lappeenranta 6
London 6
Ningbo 6
Salvador 6
Augusta 5
Baghdad 5
Guatemala City 5
Helsinki 5
Managua 5
Manchester 5
Miami 5
Mumbai 5
Norwalk 5
Poplar 5
Recife 5
São Bernardo do Campo 5
Tashkent 5
Amman 4
Ankara 4
Araras 4
Belford Roxo 4
Totale 5.418
Salva come PNG Salva come JPEG
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 348
A Novel Serum-Based Diagnosis of Alzheimer's Disease Using an Advanced Phage-Based Biochip 216
Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders 183
ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD 145
Multipotential Role of Growth Factor Mimetic Peptides for Osteochondral Tissue Engineering 143
An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer's Disease 134
Accumulation of C-terminal fragments of transactive response DNA-binding protein 43 leads to synaptic loss and cognitive deficits in human TDP-43 transgenic mice 134
The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities 133
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer‘s disease 133
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders 131
Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease 130
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice 129
BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer‘s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology 128
Amyloid beta and the longest-lived rodent: the naked mole-rat as a model for natural protection from Alzheimer's disease 126
Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to Aß oligomers accumulation 124
Generation of a Biotin-Tagged Dual-Display Phage 123
Autophagic/lysosomal dysfunction in Alzheimer's disease 122
Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome 122
Alzheimer's disease: Abeta, tau and synaptic dysfunction 119
Physiologic Response Evaluation of Human Foetal Osteoblast Cells within Engineered 3D-Printed Polylactic Acid Scaffolds 118
Maternal choline supplementation ameliorates Alzheimer's disease pathology by reducing brain homocysteine levels across multiple generations 117
Administration of a selective beta 2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease 115
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification 113
Acute tau knockdown in the hippocampus of adult mice causes learning and memory deficits 111
Amyloid deposits show complexity and intimate spatial relationship with dendrosomatic plasma membranes: an electron microscopic 3D reconstruction analysis in 3xTg-AD mice and aged canine 111
A dynamic relationship between intracellular and extracellular pools of Abeta 108
Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation? 106
Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer‘s disease 106
Necroptosis activation in Alzheimer's disease 102
Blocking Abeta42 accumulation delays the onset and progression of tau pathology via the C terminus of heat shock protein70-interacting protein: a mechanistic link between Abeta and tau pathology 99
The ubiquitin-proteasome system in Alzheimer‘s disease 93
beta(2) Adrenergic Receptor, Protein Kinase A (PKA) and c-Jun N-terminal Kinase (JNK) Signaling Pathways Mediate Tau Pathology in Alzheimer Disease Models 91
Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer‘s disease 90
mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease 89
Generation of a helper phage for the fluorescent detection of peptide-target interactions by dual-display phages 87
Engineered phage-silver nanoparticle complexes as a new tool for targeted therapies 87
Innovative Silicon-Based Sensing Strategy for the Alzheimer’s Disease Detection by Phage Display 86
PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD 85
Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology 85
Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle 84
Intracellular amyloid-beta in Alzheimer‘s disease 83
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits 83
Silicon‐Based Sensing Surface for Alzheimer's Disease Diagnosis by Phages Probes 83
Reduced protein turnover mediates functional deficits in transgenic mice expressing the 25 kDa C-terminal fragment of TDP-43 82
Increased intraneuronal resting [Ca2+] in adult Alzheimer‘s disease mice 82
Genetic suppression of beta 2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies 82
Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology 82
Experience-dependent regulation of vesicular zinc in male and female 3xTg-AD mice 80
Dyrk1 inhibition improves Alzheimer's disease-like pathology 80
Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer‘s disease mice 79
Triple-transgenic model of Alzheimer‘s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction 79
Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles 78
Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice 78
Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice 78
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer‘s disease 78
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer's disease 77
Central insulin dysregulation and energy dyshomeostasis in two mouse models of Alzheimer's disease 77
Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice 76
Enhanced neuronal excitability in the absence of neurodegeneration induces cerebellar ataxia 76
M1 receptors play a central role in modulating AD-like pathology in transgenic mice 76
Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice 75
Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease 75
Congo red and thioflavin-T analogs detect Abeta oligomers 74
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study 73
Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer‘s disease progression 73
Impaired adult neurogenesis in the dentate gyrus of a triple transgenic mouse model of Alzheimer‘s disease 73
Validation of a 2-day water maze protocol in mice 72
Modeling behavioral and neuronal symptoms of Alzheimer‘s disease in mice: a role for intraneuronal amyloid 72
Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice 71
Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles 71
Genetic Reduction of Mammalian Target of Rapamycin Ameliorates Alzheimer's Disease-Like Cognitive and Pathological Deficits by Restoring Hippocampal Gene Expression Signature 71
Glucocorticoids Exacerbate Cognitive Deficits in TDP-25 Transgenic Mice via a Glutathione-Mediated Mechanism: Implications for Aging, Stress and TDP-43 Proteinopathies 71
Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease 70
Toxic role of K+ channel oxidation in mammalian brain 70
Inhibition of soluble TNF signaling in a mouse model of Alzheimer‘s disease prevents pre-plaque amyloid-associated neuropathology 69
Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism 69
Intraneuronal Abeta causes the onset of early Alzheimer‘s disease-related cognitive deficits in transgenic mice 69
Oxidative Damage and Amyloid-beta Metabolism in Brain Regions of the Longest-Lived Rodents 68
Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer‘s disease 68
Neural stem cells improve memory in an inducible mouse model of neuronal loss 68
Identification of learning-induced changes in protein networks in the hippocampi of a mouse model of Alzheimer's disease 67
Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology 66
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments 66
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer's disease 66
CBP gene transfer increases BDNF levels and ameliorates learning and memory deficits in a mouse model of Alzheimer‘s disease 66
Genetically altering Abeta distribution from the brain to the vasculature ameliorates tau pathology 65
The role of nicotinic acetylcholine receptors in Alzheimer‘s disease 65
The Collagen Chaperone HSP47 Is a New Interactor of APP that Affects the Levels of Extracellular Beta-Amyloid Peptides 65
Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer‘s mouse models 65
How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story 65
Sortilin is required for toxic action of Aβ oligomers (AβOs): Extracellular AβOs trigger apoptosis, and intraneuronal AβOs impair degradation pathways 65
Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease 65
Life-long rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1β and NMDA signaling 65
Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice 64
Reversible epigenetic histone modifications and Bdnf expression in neurons with aging and from a mouse model of Alzheimer's disease 63
The role of mTOR signaling in Alzheimer disease 63
Methylene blue reduces Aβ levels and rescues early cognitive deficit by increasing proteasome activity 62
Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability 62
Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer‘s disease 62
mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies 58
Totale 9.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.160
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022316 0 0 0 0 5 4 41 22 5 0 3 236
2022/20231.021 107 67 48 22 36 100 21 47 544 4 20 5
2023/2024388 5 26 13 103 9 57 0 10 22 22 27 94
2024/20251.695 12 26 29 40 188 32 68 155 537 107 192 309
2025/20264.895 251 271 287 291 385 1.126 716 571 548 271 111 67
2026/20271.117 81 192 269 540 35 0 0 0 0 0 0 0
Totale 9.534